Authors: Eiermann, W Paepke, S Appfelstaedt, J Llombart-Cussac, A Eremin, J Vinholes, J Mauriac, L Ellis, M Lassus, M Chaudri-Ross, HA Dugan, M Borgs, M Semiglazov, V

Citation: W. Eiermann et al., Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study, ANN ONCOL, 12(11), 2001, pp. 1527-1532

Authors: Buzdar, AU Brady, C Chaudri-Ross, HA

Citation: Au. Buzdar et al., Letrozole in second-line therapy of advanced breast cancer: More questionsthan answers - Reply, J CL ONCOL, 19(23), 2001, pp. 4354-4355

Authors: Mouridsen, H Chaudri-Ross, HA

Citation: H. Mouridsen et Ha. Chaudri-ross, Aromatase inhibitors: Treatment of advanced breast cancer - In Reply, J CL ONCOL, 19(19), 2001, pp. 4000-4000

Authors: Mouridsen, H Gershanovich, M Sun, Y Perez-Carrion, R Boni, C Monnier, A Apffelstaedt, J Smith, R Sleeboom, HP Janicke, F Pluzanska, A Dank, M Becquart, D Bapsy, PP Salminen, E Snyder, R Lassus, M Verbeek, JA Staffler, B Chaudri-Ross, HA Dugan, M

Citation: H. Mouridsen et al., Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the international letrozole breast cancer group, J CL ONCOL, 19(10), 2001, pp. 2596-2606